Market Leadership Cisiv’s Baseline Plus platform is used by 90% of the top global pharmaceutical companies, demonstrating strong market penetration and credibility within the pharmaceutical and biotech sectors, presenting opportunities to expand customer base among industry leaders.

Innovative Collaborations Recent partnerships with Claret Capital and Clinerion highlight Cisiv’s focus on integrating real-world data sources and expanding its capabilities in emissions and EHR data, offering potential for tailored solutions in a growing RWE market.

Cost Efficiency Advantage The platform’s proven ability to reduce data management costs by 60% appeals to organizations seeking to optimize operational expenses, positioning Cisiv as a cost-effective solution for large-scale global studies.

Technology Versatility Cisiv’s modular, web-based platform provides flexible data collection and analysis tools, which can be customized to fit diverse research models, making it appealing to pharmaceutical companies planning decentralized or hybrid clinical trials.

Growth Potential With revenue estimates between 1 million and 10 million and a staff size of up to 200, Cisiv is positioned for targeted business development efforts toward mid-sized pharmaceutical firms and biotech innovators seeking advanced RWE solutions.